




Searching News Database: iodine
HSMN NewsFeed - 25 May 2021
BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System
BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System
HSMN NewsFeed - 7 Jul 2020
BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation
BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation
HSMN NewsFeed - 16 Apr 2018
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
HSMN NewsFeed - 20 Jul 2016
Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations
Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations
HSMN NewsFeed - 7 Jul 2014
Nexavar(R) (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer
Nexavar(R) (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer
HSMN NewsFeed - 18 Nov 2013
Actinium Pharmaceuticals Announces Plans For Iomab(TM)-B Phase 3 Pivotal Trial Following Meeting With FDA
Actinium Pharmaceuticals Announces Plans For Iomab(TM)-B Phase 3 Pivotal Trial Following Meeting With FDA
HSMN NewsFeed - 24 Oct 2012
Theragenics Launches Galt Centeze(TM) Centesis Drainage Catheter Line of Products
Theragenics Launches Galt Centeze(TM) Centesis Drainage Catheter Line of Products
HSMN NewsFeed - 26 Apr 2012
Theragenics Receives FDA Clearance to Market Galt VTI(TM) Valved Tearaway Introducer
Theragenics Receives FDA Clearance to Market Galt VTI(TM) Valved Tearaway Introducer
HSMN NewsFeed - 20 Feb 2012
Theragenics Acquires Core Oncology’s Prostate Brachytherapy Customer Base
Theragenics Acquires Core Oncology’s Prostate Brachytherapy Customer Base
HSMN NewsFeed - 22 Nov 2011
IsoRay Receives Final Regulatory Approval for GliaSite(R) Brain Cancer Treatment
IsoRay Receives Final Regulatory Approval for GliaSite(R) Brain Cancer Treatment
HSMN NewsFeed - 3 Nov 2011
IsoRay Announces Major International Distribution Agreement for GliaSite(R)
IsoRay Announces Major International Distribution Agreement for GliaSite(R)
HSMN NewsFeed - 31 Aug 2011
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
HSMN NewsFeed - 23 Oct 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
HSMN NewsFeed - 31 Mar 2009
GE Healthcare Announces Data from Phase III Study of AdreView in Heart Failure Patients
GE Healthcare Announces Data from Phase III Study of AdreView in Heart Failure Patients
HSMN NewsFeed - 27 Feb 2009
Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology
Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology
HSMN NewsFeed - 8 Aug 2008
Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation
Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation
HSMN NewsFeed - 23 Jul 2008
Bradmer initiates enrollment in Phase III GLASS-ART Trial in primary glioblastoma multiforme
Bradmer initiates enrollment in Phase III GLASS-ART Trial in primary glioblastoma multiforme
HSMN NewsFeed - 18 Jun 2008
Radiation Oncology Pioneer Mark Carol, MD, Joins Xoft as Chief Medical Officer
Radiation Oncology Pioneer Mark Carol, MD, Joins Xoft as Chief Medical Officer
HSMN NewsFeed - 10 Apr 2008
Symbollon Pharmaceuticals Announces Results of IoGen Phase III Clinical Trial
Symbollon Pharmaceuticals Announces Results of IoGen Phase III Clinical Trial
HSMN NewsFeed - 10 Mar 2008
Symbollon Pharmaceuticals Signs Term Sheet to Acquire Chinese Pharmaceutical Company
Symbollon Pharmaceuticals Signs Term Sheet to Acquire Chinese Pharmaceutical Company
HSMN NewsFeed - 21 Dec 2007
GE Healthcare Announces Expansion of Nuclear Cardiology Portfolio for Medical Diagnostics Business
GE Healthcare Announces Expansion of Nuclear Cardiology Portfolio for Medical Diagnostics Business
HSMN NewsFeed - 20 Dec 2007
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
HSMN NewsFeed - 17 Dec 2007
Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
HSMN NewsFeed - 24 Sep 2007
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
HSMN NewsFeed - 11 Jul 2007
Hospitals, Healthcare Providers to Save with Premier Brachytherapy Seeds Agreements
Hospitals, Healthcare Providers to Save with Premier Brachytherapy Seeds Agreements
HSMN NewsFeed - 2 Feb 2007
DRAXIS Radiopharmaceuticals Division Applies to FDA to Market Cardiac Imaging Product
DRAXIS Radiopharmaceuticals Division Applies to FDA to Market Cardiac Imaging Product
HSMN NewsFeed - 16 Jan 2007
Peregrine Pharmaceuticals' Tumor Necrosis Therapy Product for the Treatment of Lung Cancer Launched in China
Peregrine Pharmaceuticals' Tumor Necrosis Therapy Product for the Treatment of Lung Cancer Launched in China
Additional items found! 101

Members Archive contains
101 additional stories matching:
iodine
(Password required)
iodine
(Password required)